Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry

Citation
A. Pituch-noworolska et al., Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry, ANTICANC R, 18(5B), 1998, pp. 3747-3752
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
18
Issue
5B
Year of publication
1998
Pages
3747 - 3752
Database
ISI
SICI code
0250-7005(199809/10)18:5B<3747:EOCTCE>2.0.ZU;2-H
Abstract
The occurrence of circulating tumour cells in the blood of 51 patients with gastric cancer (stages I-IV) was studied using flow cytometry, cell sortin g, immunohistochemistry and reverse trascription polymerase chain reaction (RT-PCR). The lysed whole blood samples were stained with monoclonal antibo dies against common leukocyte antigen (CD45), epithelial membrane antigen ( EMA), tumour associated glycoprotein 72kD (TAG72) CD44 variants (nu 5 and n u 6) and analysed by flow cytometry within ungated or CD45(-) gated populat ions. The frequency of detection of TAG72 CD44 nu 5(+) and nu 6(+) cells wi thin CD45(-) gate was considerably increased in comparision to the ungated population. Furthermore, the presence of tumour cells was directly demonstr ated by immunostaining for cytokeratin 18 of sorted CD45- population. The p resence of CD44 nu 5(+), nu 6 cells and CD44 nu-mRNA in the blood was compa red to their expression in the primary tumour. The occurrence of circulatin g CD44 nu(+) cells was associated with their presence in the primary tumour and CD44 nu-mRNA: in the blood. The method described may provide a sensiti ve tumour marker-independent tool for detection of circulating tumour cells in cancer patients.